Cardiogenic Shock

I Introduction.- 1 Cardiogenic Shock: Clinical Features.- 2 Cardiogenic Shock: Physiological and Biochemical Concepts.- II Cardiogenic Shock Complicating Acute Coronary Syndromes.- 3 Cardiogenic Shock Complicating Non-ST-Segment Elevation Acute Coronary Syndrome.- 4 Cardiogenic Shock Complicating ST-Segment Elevation Acute Coronary Syndrome.- III Contemporary Treatment of the Patient with Cardiogenic Shock Complicating Acute Coronary Syndromes.- 5 Medical Treatment for Cardiogenic Shock.- 6 Technical Approaches to Percutaneous Revascularization in the Patient with Cardiogenic Shock.- 7 Operative Strategies for Cardiogenic Shock Complicating Acute Coronary Syndromes.- IV Mechanical Complications of Acute Myocardial Infarction Causing Cardiogenic Shock.- 8 Mechanical Complications of Acute Myocardial Infarction Causing Cardiogenic Shock.- 9 Percutaneous Treatment of Acute Mechanical Complications of Myocardial Infarction.- 10 Surgical Management of Mechanical Complications of Acute Coronary Syndromes Causing Cardiogenic Shock.- V Cardiogenic Shock Related to Valvular Heart Disease.- 11 Cardiogenic Shock Related to Valvular Heart Disease.- 12 Percutaneous Valvuloplasty in Cardiogenic Shock.- 13 Operative Management of Nonischemic Cardiogenic Shock.- VI Cardiogenic Shock Related to Other Cardiac Conditions.- 14 Myocarditis and Cardiogenic Shock.- 15 Pericardial Disease and Cardiogenic Shock.- 16 Heart Disease in the Child and Cardiogenic Shock.- 17 Congenital Heart Disease in the Adult and Cardiogenic Shock.- VII Transport, Assist Devices, and Future Perspectives.- 18 Transport of the Patient with Cardiogenic Shock.- 19 Percutaneous Mechanical Assist Devices for Severe Left Ventricular Dysfunction.- 20 Mechanical Alternatives to the Human Heart.- 21 Treatment of CardiogenicShock: Future Perspective.

" There is an interesting algorithm that is presented in a table to help predict the development of shock for those patients with a ST segment myocardial infarction. These patients are best managed with early angiography and revascularization, if possible. Antiplatelet medications, angioplasty with stents are also indicated. The use of adenosine gets attention here as well as the data that it may prevent no reflow phenomenon. Current data shows that reperfusion in acute myocardial infarction with shock has caused mortality to fall from 70-80 percent down to 50-60 percent due to aggressive management. This includes the intra-aortic balloon pumps, Swan Ganz catheterization and reperfusion with angioplasty and bypass surgery, and thrombolytic therapy. There is a good review of the mechanical complications of acute myocardial infarction shock: ventricular septal defects, severe mitral regurgitation and free wall myocardial rupture. Again, aggressive management seems to get the best results. There is a good chapter on valvular dysfunction including prosthetic valves as a cause of cardiogenic shock. Four chapters are devoted to the use of left ventricular assist devices. The chapter pointing to the future contains many interesting research opportunities, such as cell transplant and genetic engineering. This is a good review of cardiogenic shock and its multiple etiologies. This is a worthwhile addition to the cardiac literature." -Doody's Health Sciences Book Review Journal

"...this is an outstanding book that should be read by anyone who manages patients with cardiogenic shock." -Texas Heart Institute Journal

"Overall, the book is well presented. It is a good review of the diagnostic and therapeutic approaches available in hospitals with full tertiary cardiac services. It summarizes many interesting results from important multicentre cardiology trials of the last decade..." -Canadian Journal of Anesthesia

"The scope of the book is extensive....the editors